RK Xero Advance Care
RK Xero Advance Care is made to order by the compounding pharmacy. RK Xero Advance Care’s dosage has been modified to address numerous cancer pathways and assists with cancer management. RK Xero Advance Care Targets The Following: IL-1b IL-6 TNF NK Cells CXCR1 and CXCR2 CXCL8 MAPK/ERK Signaling Pathway PI3K/AKT/mTOR Pathway Wnt/β-Catenin Signaling Pathway Notch Pathway Hedgehog Pathway CXCR1 and CXCR2 FAK/AKT/FOXO3A Pathway Cancer Stem Cells RK Xero Advance Care reduces pains caused by/in the following body part: General Cancer Migraine Neck Shoulder Lower back Rheumatoid arthritis Osteoarthritis Diabetic Peripheral Neuropathy Spondylolisthesis Fibromyalgia Multiple sclerosis Sciatica Slipped disc Prostatitis Menstrual Pain/Dysmenorrhea. Parkinson’s Alzheimer’s Epilepsy Please note: Orders will now be fulfilled by batch dates. Every 15th and 30th of each month, orders will be sent out. The cutoff dates for these windows will be the 11th and 26th of the month respectively. If the order was placed after the cutoff windows, it will then be fulfilled by the next window instead.
Variants (1)
- Default Title — 70.00 MYR — In stock
AI Readiness
Good foundation, but some important product data is still missing.